Download Neuro Objectives 17

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Ligand binding assay wikipedia , lookup

Vesicular monoamine transporter wikipedia , lookup

Peptide synthesis wikipedia , lookup

Ribosomally synthesized and post-translationally modified peptides wikipedia , lookup

Proteolysis wikipedia , lookup

Biochemical cascade wikipedia , lookup

Lipid signaling wikipedia , lookup

Paracrine signalling wikipedia , lookup

Endocannabinoid system wikipedia , lookup

Signal transduction wikipedia , lookup

NMDA receptor wikipedia , lookup

G protein–coupled receptor wikipedia , lookup

Chemical synapse wikipedia , lookup

Clinical neurochemistry wikipedia , lookup

Neurotransmitter wikipedia , lookup

Transcript
Neuro Objectives 17
1.
Chemical vs. electrical synapses:
a.
Time course:
 Chemical: 1-5 msec or more (30-50 nm gap)
 Electrical: instantaneous (3.5 nm gap)
b.
Localization:
 Chemical: Can diverge/converge
 Electrical: Confined to space of transmission
c.
Directionality of transmission:
 Chemical: Unidirectional
 Electrical: Bidirectional
2.
4 steps of chemical synaptic transmission:
1.
Synthesis of neurotransmitter within presynaptic neuron
2.
Storage and release of the neurotransmitter from synaptic vesicles
3.
Interaction of the neurotransmitter with specific post-synaptic receptors
4.
Termination of neurotransmitter synaptic action
3.
Synthesis of major small molecule neurotransmitters:
a.
Acetylcholine:
choline acetyltransferase
acetyl CoA + choline
acetylcholine
(metabolism) (diet)
b.
Dopamine:
tyrosine hydroxylase
tyrosine
DOPA
(essential aa)
DOPA decarboxylase
DOPA
dopamine
c.
Norepinephrine:
dopamine β-hydroxylase
dopamine
norepinephrine
d.
Serotonin:
tryptophan hydroxylase
tryptophan
(essential aa)
5-OH-tryptophan
aromatic amino acid decarboxylase
5-OH-tryptophan
serotonin
4.
Chemical synaptic transmission events:
a.
Action potential reaches pre-synaptic bouton
b.
Voltage-gated Ca2+ channels open to increase intracellular Ca2+
c.
Ca2+ causes vesicles to fuse with bouton membrane, releasing
neurotransmitters in quantal release (all units in one vesicle at a time)
d.
Neurotransmitter interacts with post-synaptic receptors
e.
Post-synaptic receptors cause change in post-synaptic cell
5.
Mechanistic bases for EPSPs and IPSPs: EPSP is a result of a depolarizing
(excitatory) potential, usually axodendritic and caused by an influx of Na+
through a ligand-gated Na+ channel. An IPSP is a result of a hyperpolarizing
(inhibitory) potential, usually axosomatic and caused by an influx of Cl- through a
ligand-gated Cl- channel or outflux of K+ through a ligand-gated K+ channel.
Integration at the axon hillock: Integration of EPSPs and IPSPs occurs
throughout the cell, but at the axon hillock (where the threshold to fire an action
potential is the lowest) the integration is especially important due to its capability
to fire an action potential.
6.
Termination of:
a.
small molecule neurotransmitters:
a.
reuptake: glutamate, aspartate, GABA, glycine, norepinephrine,
dopamine, and serotonin are all pumped back into the presynaptic cell
against a concentration gradient
b.
metabolism: acetylcholine (acetylcholinesterase), norepinephrine
(MAO, COMT to form MHPG), dopamine (MAO, COMT to form HVA),
and serotonin (MAO to form 5-HIAA) are metabolized by the body and
levels of their metabolites can quantitate activity of the neurotransmitter
b.
peptide neurotransmitters:
all metabolized either by endopeptidases (cleaving the middle of the
protein) or exopeptidases (cleaving the ends of the protein)
7.
Metabolism of biogenic amine neurotransmitters:
a.
Dopamine: MAO, COMT to form HVA
b.
Norepinephrine: MAO, COMT to form MHPG
c.
Serotonin: MAO to form 5-HIAA
8.
Small molecule vs. peptide neurotransmitters:
a.
synthesis:
 Small molecule: enzymes in presynaptic nerve terminal
 Peptide: cell body from specific mRNAs
b.
processing:
 Small molecule: enzymatic buildup of precursors
 Peptide: enzymatic cleavage of large polypeptides
c.
d.
storage:
 Small molecule: small vesicles
 Peptide: large vesicles
termination:
 Small molecule: reuptake, diffusion, enzymatic catabolism
 Peptide: enzymatic hydrolysis
9.
Time courses of action for:
a. neurotransmitter-gated ion channels: milliseconds (short-lived)
b. receptors linked to second messengers: seconds to hours (long-lived)
10.
Neurotransmitter-gated ion channels:
a.
Nicotinic cholinergic receptor (activated by acetylcholine): Nicotine acts
as an agonist, primary excitatory neurotransmitter of the PNS, increase in
1.5 Na+ to 1 K+ permeability for depolarization (muscle contraction)
b.
NMDA receptor (activated by glutamate): NMDA acts as an agonist,
primary excitatory neurotransmitter of the CNS, increase in Na+ and Ca2+
influx for depolarization (learning and memory)
c.
GABA receptor (activated by GABA): primary inhibitory neurotransmitter
of the CNS, increase in Cl- influx for hyperpolarization
11.
Role of G-proteins in receptor activation:
Intracellular G-protein binds to GTP causing dissociation into 3 subunits. These
subunits activate PLC or adenylate cyclase. GTP is hydrolyzed back to GDP by
intrinsic GTPases and the G-proteins bind back to their receptors.
 cAMP formation: when G-proteins bind adenylate cyclase, it forms cAMP
from ATP which activates enzymes including PKA. cAMP is terminated
by phosphodiesterase.
o Positive coupling: noradrenergic beta-adrenergic receptor,
dopamine D1 receptor, histamine H2 receptor
o Negative coupling: noradrenergic alpha2-adrenergic receptor,
dopamine D2 receptor, muscarinic M2 receptor
 PI turnover: PI is a phospholipid in the bilayer that can be doubly
phosphorylated to make PIP2. When G-proteins activate PLC, PLC
cleaves PIP2 to make IP3 and DAG.
o IP3 increases Ca2+ concentration which feeds back to degrade IP3
via Ca2+ dependent enzymes
o DAG activates PKC to phosphorylate downstream proteins.
 Coupling: noradrenergic alpha1-adrenergic receptor,
muscarinic M1 receptor, serotonin 5HT2 receptor